Replies to post #184439 on Bioelectronics Corp (BIEL)

[pinhigh]

As you say Hawk..."closed deals and sales" will be the primary pps movers. It will be interesting to see if RecoveryRX passage by the FDA has any impact. That one is a blockbuster. Dr. Sree Koneru believes it holds Standard of Care potential. As I understand it Mundipharma reps will be able push RecoveryRX abroad unimpeded. Nice to know should the FDA prove uncooperative. Go Biel$$$

[art2426]

>>>Show us proof that any of those opportunities were turned down by AW and if so what are the details.<<<



You see Hawk, if a CEO hears of such talk by his stockholders as this and knows how damaging that could be/is to the stock price and all his investors that he is supposed to be working FOR, and is totally FALSE information, shouldn't he immediately calm the storm and address to his stockholders, that this is totally false information. But he has NOT, so we are left to believe that it is TRUE. And if it IS TRUE, then explain to us, WHY he has turned down deals. That is important information that needs to be told to stockholders. SERIOUS INFORMATION! We have been lingering in the triple zeros for years, we need to know what is being done to correct that. Because to correct that, we know we MUST HEAR about DEALS like the ones being rumored, that HE turned down

WHY!!!!